TY - JOUR T1 - Proceedings of the 2020 GRAPPA Collaborative Research Network (CRN) Meeting JF - The Journal of Rheumatology JO - J Rheumatol SP - 4 LP - 9 DO - 10.3899/jrheum.201667 VL - 97 AU - Carmel Stober AU - Deepak R. Jadon AU - April W. Armstrong AU - Vinod Chandran AU - Maarten de Wit AU - Philip S. Helliwell AU - Philip J. Mease AU - Alexis Ogdie AU - Denis O’Sullivan AU - Stephen R. Pennington AU - Thorvardur Löve AU - Alberto Cauli AU - Leonieke van Mens AU - Robin Waxman AU - Jose U. Scher AU - Anne Barton AU - Christopher T. Ritchlin AU - Oliver FitzGerald Y1 - 2021/06/01 UR - http://www.jrheum.org/content/97/4.abstract N2 - At the 2020 Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)-Collaborative Research Network (CRN) annual meeting, the GRAPPA-CRN group presented a pilot investigator-initiated study protocol to test electronic case report forms (eCRFs) and proposed Standardized Operating Procedures (SOPs) to evaluate biomarkers of psoriatic arthritis (PsA) associated with axial disease. The progress on 3 studies was also presented: BioDAM PsA (Biomarkers as Predictors of structural DAMage in PsA; to validate soluble biomarkers as predictors of structural damage in PsA), PreventPsA (examining the development of PsA and risk factors among patients with psoriasis and no arthritis), and PredictORPsA (Predicting Treatment respOnse in patients with eaRly PsA; in collaboration with Pfizer using samples from the Oral Psoriatic Arthritis TriaL [OPAL], to identify biomarkers of treatment response). GRAPPA-CRN funding partnerships and applications are also underway with both the Innovative Medicines Initiative (IMI) in Europe and Accelerating Medicines Partnerships (AMP) 2.0 in the USA, and the progress of these applications and associated objectives were presented. ER -